New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
BY MATTHEW PERRONE WASHINGTON (AP) - U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year. RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly. The Food and Drug Administration approved the injection for infants and children up